RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
There is increasing interest in the delivery of drugs to the lungs to treat a variety of diseases. The spatial and temporal influence of deposition and clearance mechanisms on the fate of inhaled materials are important factors in the control of delivery of therapeutic agents to the lungs. Balancing anatomical and physiological considerations with pharmaceutical properties dictates the therapeutic potential of any pharmacological and immunological strategy. A brief introduction of aerosol properties and inhaler technology is followed by considerations of in vitro and in vivo disposition in the context of controlled drug release for targeting anatomical, physiological and therapeutic targeting. Comprehensive assessment of drug delivery to and disposition from the lungs is required if controlled and targeted strategies are to be successful